Literature DB >> 19125092

Primary mixed glioneuronal tumor of the central nervous system in a patient with noonan syndrome: a case report and review of the literature.

Courtney B Sherman1, Afshan Ali-Nazir, Ignacio Gonzales-Gomez, Jonathan L Finlay, Girish Dhall.   

Abstract

Noonan syndrome is an autosomal dominant condition with variable phenotypic expression. Although an association between Noonan syndrome and various neoplasms has been identified, a relationship with primary glial or neuronal tumors of the central nervous system (CNS) has not yet been established. We describe the case of a 6-year-old male patient with Noonan syndrome and leptomeningeally disseminated low-grade mixed glioneuronal tumor. After a literature review, this case emerges as the third patient to present with Noonan syndrome and primary CNS glial tumor and the first with mixed glioneuronal tumor, indicating the possible association between these individual entities.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19125092     DOI: 10.1097/MPH.0b013e31818ab2cf

Source DB:  PubMed          Journal:  J Pediatr Hematol Oncol        ISSN: 1077-4114            Impact factor:   1.289


  5 in total

Review 1.  Rosette forming glioneuronal tumor in association with Noonan syndrome: pathobiological implications.

Authors:  M Karafin; G I Jallo; M Ayars; C G Eberhart; F J Rodriguez
Journal:  Clin Neuropathol       Date:  2011 Nov-Dec       Impact factor: 1.368

2.  Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation.

Authors:  Marjolijn C J Jongmans; Ineke van der Burgt; Peter M Hoogerbrugge; Kees Noordam; Helger G Yntema; Willy M Nillesen; Roland P Kuiper; Marjolijn J L Ligtenberg; Ad Geurts van Kessel; J Han J M van Krieken; Lambertus A L M Kiemeney; Nicoline Hoogerbrugge
Journal:  Eur J Hum Genet       Date:  2011-03-16       Impact factor: 4.246

Review 3.  Inside the Noonan "universe": Literature review on growth, GH/IGF axis and rhGH treatment: Facts and concerns.

Authors:  Stefano Stagi; Vittorio Ferrari; Marta Ferrari; Manuela Priolo; Marco Tartaglia
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-18       Impact factor: 6.055

Review 4.  Noonan syndrome.

Authors:  Amy E Roberts; Judith E Allanson; Marco Tartaglia; Bruce D Gelb
Journal:  Lancet       Date:  2013-01-10       Impact factor: 79.321

5.  Integrated tumor and germline whole-exome sequencing identifies mutations in MAPK and PI3K pathway genes in an adolescent with rosette-forming glioneuronal tumor of the fourth ventricle.

Authors:  Frank Y Lin; Katie Bergstrom; Richard Person; Abhishek Bavle; Leomar Y Ballester; Sarah Scollon; Robin Raesz-Martinez; Andrew Jea; Sherri Birchansky; David A Wheeler; Stacey L Berg; Murali M Chintagumpala; Adekunle M Adesina; Christine Eng; Angshumoy Roy; Sharon E Plon; D Williams Parsons
Journal:  Cold Spring Harb Mol Case Stud       Date:  2016-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.